Q2 FY2026 · ended Jun 30, 2026 · Revenue $210.93M, +3.8% YoY · Filed Aug 5, 2026
Orthofix Medical Inc. (OFIX) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $210.9 million and a net loss of $15.8 million. Free cash flow was -$18.9 million. As of Jun 30, 2026 it held $103.8 million in cash and investments and $261.9 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- OFIX (Nasdaq)
- Fiscal year ends
- December 23
- Headquarters
- Lewisville, TX
- SEC filer status
- Accelerated filer
- SEC CIK
- 884624
- Former names
- ORTHOFIX INTERNATIONAL N V (until Aug 1, 2018)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $210.9M | $196.7M | $219.9M | $205.6M | $203.1M |
| Operating income | -$8.1M | -$14.4M | $494,000 | -$17.0M | -$16.0M |
| Net income | -$15.8M | -$20.9M | -$2.2M | -$22.8M | -$14.1M |
| Diluted EPS | -$0.39 | -$0.52 | -$0.06 | -$0.57 | -$0.36 |
| Operating cash flow | -$6.2M | -$17.6M | $27.7M | $12.4M | $11.6M |
| Free cash flow | -$18.9M | -$28.3M | $16.8M | $2.5M | $4.5M |
| Total assets | $873.0M | $886.6M | $850.6M | $832.6M | $837.2M |
| Total liabilities | $443.8M | $451.4M | $400.6M | $390.1M | $378.8M |
| Stockholders' equity | $429.2M | $435.2M | $450.0M | $442.5M | $458.3M |
| Cash and investments | $103.8M | $120.3M | $82.0M | $62.9M | $65.6M |
| Total debt | $261.9M | $262.3M | $203.8M | $204.5M | $204.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 2, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 21, 2026 | May 21, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
All 1007 Orthofix Medical Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.